Novo Nordisk
Global healthcare company with 95 years of innovation and leadership in diabetes care. Learn more
Launch date
Employees
Market cap
$600.4b
Enterprise valuation
$599.6b (Public information from Sep 2024)
Share price
$132.06 NVO
Company register number 24256790
Gladsaxe Municipality Capital Region of Denmark (HQ)
Corporate Venture Fund: Novo Ventures, Novo Holdings
No columns specified